T3 Companies, LLC

Position in IFRX — InflaRx N.V.

CIK 2052441 NEW YORK, NY

Position in IFRX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$741,471

+$481,305 QoQ

Shares Held

331,014

+13.7% QoQ

Ownership

0.225%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

#23

of 62 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names. IFRX ranks #2 (27.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	7,815	$1,041,426
2	IFRX	InflaRx N.V. This page	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc.	18,900	$615,195
4	CLDX	Celldex Therapeutics, Inc.	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$741,471	331,014	+13.7%	Shares	Sole	2026-07-27
2026-03-31	$260,166	291,014	0.0%	Shares	Sole	2026-05-07
2025-12-31	$293,924	291,014	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.